WOLVERINE TRADING, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$61,854
-76.2%
36,600
-61.6%
0.00%
Q2 2023$259,428
+168359.7%
95,378
+9.3%
0.00%
Q1 2023$154
-72.5%
87,287
-21.1%
0.00%
-100.0%
Q4 2022$561
-99.9%
110,700
+9.2%
0.00%0.0%
Q3 2022$501,000
+291.4%
101,400
+198.2%
0.00%
Q2 2022$128,000
-77.2%
34,000
-64.4%
0.00%
Q1 2022$562,000
+49.5%
95,482
+62.4%
0.00%
Q4 2021$376,000
-44.6%
58,800
+25.9%
0.00%
-100.0%
Q2 2021$679,000
-74.2%
46,700
-57.9%
0.00%
-75.0%
Q1 2021$2,632,000110,8500.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders